Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
about
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a reviewThe Role of ERK1/2 in the Development of Diabetic CardiomyopathyTherapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathyMolecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractilityUpregulation of PPARbeta/delta is associated with structural and functional changes in the type I diabetes rat diaphragmCharacterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line.MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats.Metabolic dysfunction in diabetic cardiomyopathy.Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to benchPeroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.Ginseng is useful to enhance cardiac contractility in animals.Merit of ginseng in the treatment of heart failure in type 1-like diabetic rats.PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.Metabolic enzymes dysregulation in heart failure: the prospective therapy.Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells.Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions.Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin.Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.Liver lipid content is reduced in rat given 7-day administration of angiotensin II.Activation of β-adrenoceptors by dobutamine may induce a higher expression of peroxisome proliferator-activated receptors δ (PPARδ) in neonatal rat cardiomyocytes
P2860
Q26866784-2AB3DEA0-ABC2-41E6-8470-09F94E2EB5D2Q28075539-8FB02242-9265-4562-91EA-84EC137B5B78Q28391746-7222A815-36BC-49F6-82E3-78D56C5ED522Q28566976-22C9EA76-0EB0-4F55-BB6C-D1CD707EEB18Q33632253-598F1247-50CA-40ED-994C-73A89186CDB3Q34919685-DDA2EFCA-4F37-41DA-8752-15C265E114A5Q35920226-A286154F-21A4-484D-BE0C-BC1EA9B229D8Q36261125-1AC01985-49DD-4DBD-8827-5D88591FC518Q36701970-F712329B-4EEA-48D4-BDDB-3584393F0EBFQ36930481-8ECEBFD6-849F-4A6B-923E-BAAD16047496Q37171547-ED51DFED-9635-4C8D-97D2-67A121FEDDE7Q37578702-9EDA81E4-D6FD-414D-819C-A6415F823903Q37598593-27D96C1F-8C3D-42B6-9078-E889088BF929Q37686746-860ACAE5-D9D8-4AC1-8CB9-60443B022369Q37996437-E81F2962-ABD7-47AE-B743-464DAA60E0E3Q39011735-CEAF692D-B982-4A70-A4A3-E5A4F0A7894AQ39175196-E364C8D4-BE84-4858-9159-1E1137B03ECDQ42641988-F5B43221-82E4-43F1-A943-13B28C1329CEQ42909119-8D827E57-95F4-44A4-B9C2-5E8FC8704E7CQ46386818-0EEC28B4-E346-4D09-BD4E-2A9C88C826E0Q49601942-E0E2234C-0F20-479F-B4B8-B9609D5FDAF4Q50026330-BE4A0B74-5C52-4C54-B0DC-632486FC3639Q50528484-9F7C71DF-A33B-47AB-8F82-64773A0BE976Q58914701-C6A519C8-4E65-4D55-A549-1CDFF33C3D1F
P2860
Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
description
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Oktober 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/10/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/10/01)
@nl
наукова стаття, опублікована в жовтні 2008
@uk
مقالة علمية (نشرت في أكتوبر 2008)
@ar
name
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@ast
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@en
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@nl
type
label
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@ast
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@en
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@nl
prefLabel
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@ast
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@en
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@nl
P2093
P2860
P3181
P356
P1476
Decrease of peroxisome prolife ...... ozotocin-induced diabetic rats
@en
P2093
Bu-Chin Yu
Chen-Kuei Chang
Horng-Yih Ou
Juei-Tang Cheng
Kai-Chun Cheng
P2860
P3181
P356
10.1093/CVR/CVN172
P577
2008-10-01T00:00:00Z